EP0855029A4 - Ein assay mit hohern durchsatz unter verwendung von fusionsprotein - Google Patents

Ein assay mit hohern durchsatz unter verwendung von fusionsprotein

Info

Publication number
EP0855029A4
EP0855029A4 EP96931529A EP96931529A EP0855029A4 EP 0855029 A4 EP0855029 A4 EP 0855029A4 EP 96931529 A EP96931529 A EP 96931529A EP 96931529 A EP96931529 A EP 96931529A EP 0855029 A4 EP0855029 A4 EP 0855029A4
Authority
EP
European Patent Office
Prior art keywords
fusion proteins
high throughput
throughput assay
assay
fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96931529A
Other languages
English (en)
French (fr)
Other versions
EP0855029A1 (de
Inventor
Scott P Salowe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603486.3A external-priority patent/GB9603486D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0855029A1 publication Critical patent/EP0855029A1/de
Publication of EP0855029A4 publication Critical patent/EP0855029A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493—Immunosupressants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
EP96931529A 1995-09-15 1996-09-11 Ein assay mit hohern durchsatz unter verwendung von fusionsprotein Withdrawn EP0855029A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US382495P 1995-09-15 1995-09-15
US3824 1995-09-15
GB9603486 1996-02-20
GBGB9603486.3A GB9603486D0 (en) 1996-02-20 1996-02-20 A high throughputassay using fusion proteins
PCT/US1996/014563 WO1997010502A1 (en) 1995-09-15 1996-09-11 A high throughput assay using fusion proteins

Publications (2)

Publication Number Publication Date
EP0855029A1 EP0855029A1 (de) 1998-07-29
EP0855029A4 true EP0855029A4 (de) 2000-03-08

Family

ID=26308762

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96931529A Withdrawn EP0855029A4 (de) 1995-09-15 1996-09-11 Ein assay mit hohern durchsatz unter verwendung von fusionsprotein

Country Status (4)

Country Link
EP (1) EP0855029A4 (de)
JP (1) JP2000501171A (de)
CA (1) CA2231385A1 (de)
WO (1) WO1997010502A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
WO1998041866A1 (en) * 1997-03-14 1998-09-24 Merck & Co., Inc. A high throughput assay using fusion proteins
IL142137A0 (en) * 1998-10-19 2002-03-10 Ariad Gene Therapeutics Inc Materials and methods involving conditional retention domains
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
MXPA03011455A (es) 2001-06-22 2004-04-05 Hoffmann La Roche Complejo soluble que comprende glucoproteina de superficie retroviral.
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1892530A1 (de) * 2006-08-25 2008-02-27 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Bestimmung der Transportaktivität eines Transportproteins
CA2711765A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
EP3008192B1 (de) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Proteinangereicherte mikrovesikel und verfahren zur herstellung und verwendung davon

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154734A1 (de) * 1984-03-15 1985-09-18 Immunex Corporation Test zur sofortigen Feststellung von Liganden, Testsatz und seine Herstellung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154734A1 (de) * 1984-03-15 1985-09-18 Immunex Corporation Test zur sofortigen Feststellung von Liganden, Testsatz und seine Herstellung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BANKS, M. ET AL.: "Soluble Interleukin-5 Receptor alpha-Chain Binding Assays: Use for Screening and Analysis of Interleukin-5 Mutants", ANALYTICAL BIOCHEMISTRY, vol. 230, no. 2, 1995, pages 321 - 328, XP002113269 *
See also references of WO9710502A1 *

Also Published As

Publication number Publication date
CA2231385A1 (en) 1997-03-20
WO1997010502A1 (en) 1997-03-20
EP0855029A1 (de) 1998-07-29
JP2000501171A (ja) 2000-02-02

Similar Documents

Publication Publication Date Title
GB9718609D0 (en) Fusion protein
AU6255096A (en) Pegylated modified proteins
AU9482098A (en) Fusion protein systems
EP0871777A4 (de) Elektronischer analysetest für biomoleküle an einer feste phase
AU1115897A (en) Nima interacting proteins
GB9525474D0 (en) Antifungal proteins
IL122898A0 (en) Allergan -XCD32 fusion proteins
AU5681498A (en) A ctla4-ig fusion protein having high titer
GB9510830D0 (en) Proteins
AU9798398A (en) Gfp-annexin fusion proteins
EP0855029A4 (de) Ein assay mit hohern durchsatz unter verwendung von fusionsprotein
AU5635896A (en) Recombinant endotoxin-neutralizing proteins
AU1373395A (en) Vpr receptor protein
AU7520396A (en) Abl-interactor protein
AU5284296A (en) Immune-evading proteins
GB9519865D0 (en) Protein
GB9605210D0 (en) A high throughput assay using fusion proteins
AU6153396A (en) E6ap-binding proteins
GB9622436D0 (en) Protein
GB9603486D0 (en) A high throughputassay using fusion proteins
GB9511109D0 (en) Receptor proteins
GB9524341D0 (en) Proteins
GB9713150D0 (en) Fusion proteins
GB9509102D0 (en) Modified proteins
GB9416553D0 (en) Novel receptor proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980415

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000126

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/53 A, 7G 01N 33/534 B, 7G 01N 33/543 B, 7G 01N 33/542 B, 7G 01N 33/60 B

17Q First examination report despatched

Effective date: 20010713

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011124